| 4.66 -0.44 (-8.63%) | 09-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.05 | 1-year : | 7.07 |
| Resists | First : | 5.18 | Second : | 6.05 |
| Pivot price | 4.4  |
|||
| Supports | First : | 4.47 | Second : | 4.03 |
| MAs | MA(5) : | 4.72 |
MA(20) : | 4.34 |
| MA(100) : | 4.17 |
MA(250) : | 3.14 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 81.6 |
D(3) : | 89.8 |
| RSI | RSI(14): 55.9 |
|||
| 52-week | High : | 5.59 | Low : | 1.58 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CLOV ] has closed below upper band by 26.4%. Bollinger Bands are 6.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.06 - 5.09 | 5.09 - 5.11 |
| Low: | 4.54 - 4.57 | 4.57 - 4.59 |
| Close: | 4.61 - 4.66 | 4.66 - 4.69 |
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Wed, 16 Sep 2026
Clover Health Investments (NASDAQ:CLOV) Upgraded to "Hold" at Zacks Research - MarketBeat
Tue, 15 Sep 2026
Clover Health CEO, Medicare advantage, Jamie Reynoso sells $44,324 in CLOV shares - Investing.com
Tue, 15 Sep 2026
Karen Soares Sells 6,846 Shares of Clover Health Investments (NASDAQ:CLOV) Stock - MarketBeat
Tue, 15 Sep 2026
Clover Health (NASDAQ: CLOV) Medicare chief sells 9,273 shares to cover RSU taxes - Stock Titan
Tue, 15 Sep 2026
Former Clover Health (NASDAQ: CLOV) exec lines up roughly $1M stock sale - Stock Titan
Tue, 15 Sep 2026
Clover Health officer plans 300K-share, $1.4M sale | CLOV SEC Filing - Form 144 - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 435 (M) |
| Shares Float | 413 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 33.9 (%) |
| Shares Short | 26,140 (K) |
| Shares Short P.Month | 28,750 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.7 |
| Profit Margin | -0.8 % |
| Operating Margin | 3.7 % |
| Return on Assets (ttm) | -1.8 % |
| Return on Equity (ttm) | -5.1 % |
| Qtrly Rev. Growth | 55.5 % |
| Gross Profit (p.s.) | 1.05 |
| Sales Per Share | 5.69 |
| EBITDA (p.s.) | -0.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 77 (M) |
| Levered Free Cash Flow | 69 (M) |
| PE Ratio | -93.2 |
| PEG Ratio | 0 |
| Price to Book value | 6.56 |
| Price to Sales | 0.81 |
| Price to Cash Flow | 26.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|